AbbVie, Inc. (ABBV)
210.39
-0.38
(-0.18%)
USD |
NYSE |
May 15, 16:00
210.63
+0.24
(+0.11%)
After-Hours: 20:00
AbbVie Total Liabilities (Quarterly) : 143.08B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 83.31B |
| Biogen, Inc. | 10.83B |
| Gilead Sciences, Inc. | 32.85B |
| Regeneron Pharmaceuticals, Inc. | 9.445B |
| Moderna, Inc. | 4.08B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 136.46B |
| Shareholders Equity (Quarterly) | -6.656B |
| Debt to Equity Ratio | -10.95 |
| Current Ratio | 0.7964 |
| Net Debt Paydown Yield | -0.26% |